Document is current
Any future updates will be listed below
-
Authors
Yang, Hongmei https://orcid.org/0000-0002-9048-2546
Amal, Haitham
Tannenbaum, Steven R.
Lipton, Stuart A. https://orcid.org/0000-0002-3490-1259
-
Funding
Funding for this research was provided by:
California Institute for Regenerative Medicine (DISC4-16292 ReMIND-L)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (U01 AG088679, R35 AG071734, RF1 AG057409, R01 AG056259, R56 AG065372, R01 AG056259)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DP1 DA041722)
Science and Technology Development Planning Project of Jilin Province, China
- License Information
-
More Information
Article History
Received: 2 January 2025
Accepted: 24 September 2025
First Online: 19 November 2025
Competing interests
: H.A. is the scientific founder of Point6 Bio, a biotechnology company focusing on multiomics discoveries, including S-nitrosylated proteins, for molecular insight into autism spectrum disorder. S.A.L. serves on the scientific advisory board of Point6 Bio. The other authors declare no competing interests.
